Viewing Study NCT03873402


Ignite Creation Date: 2025-12-25 @ 4:01 AM
Ignite Modification Date: 2026-03-12 @ 12:55 AM
Study NCT ID: NCT03873402
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-03-12
First Post: 2019-03-11
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study of Nivolumab Combined With Ipilimumab Versus Nivolumab Alone in Participants With Advanced Kidney Cancer
Sponsor: Bristol-Myers Squibb
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Renal Cell Carcinoma View
Keywords: